Tesamorelin 10mg

Also referenced as: tesamorelin · research · growth hormone research

Tesamorelin mimics natural human GHRH by binding to pituitary GHRH receptors, triggering pulsatile growth hormone secretion and consequent IGF-1 elevation. Published literature on Tesamorelin is summarised here for laboratory reference only: nothing on this page is a therapeutic claim, a dosing instruction or a direction for human or veterinary use. This product is supplied as 10mg. Supplier availability or vial strength must not be read as a clinical dose or as evidence of efficacy. For laboratory research use only. Not intended for human consumption.

$146.99

In stock — ships from Australia

Specification

10mg

Form

Lyophilised powder or solution as supplied

Purity

98.709%

Purity method

HPLC-UV (third-party laboratory)

Identity method

[INFORMATION REQUIRED]

Batch

PR-2608

Lot

PR-2608-TSM10

Storage

Lyophilised powder: store at −20 °C or below, desiccated and protected from light; short periods at 2–8 °C are tolerated during transport. Allow the vial to reach room temperature before opening to avoid condensation. Once placed in solution, the material is unstable at ambient temperature — hold reconstituted material at 2–8 °C for short-term laboratory work or at −20 °C in single-use aliquots, and avoid repeated freeze–thaw cycles. Not for human or veterinary use.

Stock

In stock